Development of a Novel Combination Therapy targeting MET and LGR5 to overcome Colorectal Cancer Resistance is a research paper (2022). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5R01CA226894-03
Mechanisms and therapeutic targeting of colon cancer stem cell plasticity
National Institutes of Health
Grant: 1R21CA270716-01
Novel Antibody-Drug Conjugate Combination Therapy for Treating Colorectal Cancer
Fields of Study
Keywords
Sustainable Development Goals